Canada markets closed

Catalyst Pharmaceuticals, Inc. (CPRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
15.87-0.05 (-0.31%)
At close: 04:00PM EDT
16.20 +0.33 (+2.08%)
After hours: 07:40PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.87B
Enterprise Value 1.57B
Trailing P/E 28.34
Forward P/E 11.38
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.48
Price/Book (mrq)3.34
Enterprise Value/Revenue 3.81
Enterprise Value/EBITDA 13.75

Trading Information

Stock Price History

Beta (5Y Monthly) 0.89
52-Week Change 337.40%
S&P500 52-Week Change 326.14%
52 Week High 317.50
52 Week Low 311.09
50-Day Moving Average 315.68
200-Day Moving Average 314.42

Share Statistics

Avg Vol (3 month) 31.32M
Avg Vol (10 day) 31.04M
Shares Outstanding 5118.11M
Implied Shares Outstanding 6118.49M
Float 8101.66M
% Held by Insiders 16.21%
% Held by Institutions 183.20%
Shares Short (Apr 30, 2024) 47.71M
Short Ratio (Apr 30, 2024) 45.99
Short % of Float (Apr 30, 2024) 48.12%
Short % of Shares Outstanding (Apr 30, 2024) 46.53%
Shares Short (prior month Mar 28, 2024) 46.05M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 15.83%
Operating Margin (ttm)27.54%

Management Effectiveness

Return on Assets (ttm)9.29%
Return on Equity (ttm)14.55%

Income Statement

Revenue (ttm)411.35M
Revenue Per Share (ttm)3.77
Quarterly Revenue Growth (yoy)15.40%
Gross Profit (ttm)N/A
EBITDA 114.04M
Net Income Avi to Common (ttm)65.12M
Diluted EPS (ttm)0.56
Quarterly Earnings Growth (yoy)-21.30%

Balance Sheet

Total Cash (mrq)310.41M
Total Cash Per Share (mrq)2.63
Total Debt (mrq)3.47M
Total Debt/Equity (mrq)0.62%
Current Ratio (mrq)5.09
Book Value Per Share (mrq)4.76

Cash Flow Statement

Operating Cash Flow (ttm)163.46M
Levered Free Cash Flow (ttm)-34.3M